1 Angiotensin II Receptor Blockers Market Overview 1.1 Product Overview and Scope of Angiotensin II Receptor Blockers 1.2 Angiotensin II Receptor Blockers Segment by Type 1.2.1 Global Angiotensin II Receptor Blockers Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Azilsartan 1.2.3 Candesartan 1.2.4 Eprosartan 1.2.5 Irbesartan 1.2.6 Losartan 1.2.7 Olmesartan 1.2.8 Telmisartan 1.2.9 Valsartan 1.3 Angiotensin II Receptor Blockers Segment by Application 1.3.1 Angiotensin II Receptor Blockers Sales Comparison by Application: (2021-2027) 1.3.2 Chronic Kidney Diseases 1.3.3 Heart Failure 1.3.4 Kidney Failure in Diabetes 1.4 Global Angiotensin II Receptor Blockers Market Size Estimates and Forecasts 1.4.1 Global Angiotensin II Receptor Blockers Revenue 2016-2027 1.4.2 Global Angiotensin II Receptor Blockers Sales 2016-2027 1.4.3 Angiotensin II Receptor Blockers Market Size by Region: 2016 Versus 2021 Versus 2027 2 Angiotensin II Receptor Blockers Market Competition by Manufacturers 2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2016-2021) 2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Angiotensin II Receptor Blockers Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Angiotensin II Receptor Blockers Manufacturing Sites, Area Served, Product Type 2.5 Angiotensin II Receptor Blockers Market Competitive Situation and Trends 2.5.1 Angiotensin II Receptor Blockers Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue 2.5.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Angiotensin II Receptor Blockers Retrospective Market Scenario by Region 3.1 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country 3.3.1 North America Angiotensin II Receptor Blockers Sales by Country 3.3.2 North America Angiotensin II Receptor Blockers Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country 3.4.1 Europe Angiotensin II Receptor Blockers Sales by Country 3.4.2 Europe Angiotensin II Receptor Blockers Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Region 3.5.1 Asia Pacific Angiotensin II Receptor Blockers Sales by Region 3.5.2 Asia Pacific Angiotensin II Receptor Blockers Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country 3.6.1 Latin America Angiotensin II Receptor Blockers Sales by Country 3.6.2 Latin America Angiotensin II Receptor Blockers Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country 3.7.1 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country 3.7.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Angiotensin II Receptor Blockers Historic Market Analysis by Type 4.1 Global Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021) 4.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2016-2021) 4.3 Global Angiotensin II Receptor Blockers Price by Type (2016-2021) 5 Global Angiotensin II Receptor Blockers Historic Market Analysis by Application 5.1 Global Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021) 5.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2016-2021) 5.3 Global Angiotensin II Receptor Blockers Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck & Co. 6.1.1 Merck & Co. Corporation Information 6.1.2 Merck & Co. Description and Business Overview 6.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck & Co. Product Portfolio 6.1.5 Merck & Co. Recent Developments/Updates 6.2 AstraZeneca 6.2.1 AstraZeneca Corporation Information 6.2.2 AstraZeneca Description and Business Overview 6.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.2.4 AstraZeneca Product Portfolio 6.2.5 AstraZeneca Recent Developments/Updates 6.3 Novartis 6.3.1 Novartis Corporation Information 6.3.2 Novartis Description and Business Overview 6.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Novartis Product Portfolio 6.3.5 Novartis Recent Developments/Updates 6.4 Teva 6.4.1 Teva Corporation Information 6.4.2 Teva Description and Business Overview 6.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Teva Product Portfolio 6.4.5 Teva Recent Developments/Updates 6.5 Bayer 6.5.1 Bayer Corporation Information 6.5.2 Bayer Description and Business Overview 6.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Bayer Product Portfolio 6.5.5 Bayer Recent Developments/Updates 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Corporation Information 6.6.2 GlaxoSmithKline Description and Business Overview 6.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.6.4 GlaxoSmithKline Product Portfolio 6.6.5 GlaxoSmithKline Recent Developments/Updates 6.7 Sun Pharmaceutical 6.6.1 Sun Pharmaceutical Corporation Information 6.6.2 Sun Pharmaceutical Description and Business Overview 6.6.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sun Pharmaceutical Product Portfolio 6.7.5 Sun Pharmaceutical Recent Developments/Updates 6.8 Mylan 6.8.1 Mylan Corporation Information 6.8.2 Mylan Description and Business Overview 6.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Mylan Product Portfolio 6.8.5 Mylan Recent Developments/Updates 7 Angiotensin II Receptor Blockers Manufacturing Cost Analysis 7.1 Angiotensin II Receptor Blockers Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Angiotensin II Receptor Blockers 7.4 Angiotensin II Receptor Blockers Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Angiotensin II Receptor Blockers Distributors List 8.3 Angiotensin II Receptor Blockers Customers 9 Angiotensin II Receptor Blockers Market Dynamics 9.1 Angiotensin II Receptor Blockers Industry Trends 9.2 Angiotensin II Receptor Blockers Growth Drivers 9.3 Angiotensin II Receptor Blockers Market Challenges 9.4 Angiotensin II Receptor Blockers Market Restraints 10 Global Market Forecast 10.1 Angiotensin II Receptor Blockers Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Type (2022-2027) 10.2 Angiotensin II Receptor Blockers Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Application (2022-2027) 10.3 Angiotensin II Receptor Blockers Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Angiotensin II Receptor Blockers by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Angiotensin II Receptor Blockers by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Angiotensin II Receptor Blockers Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Angiotensin II Receptor Blockers Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Angiotensin II Receptor Blockers Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Angiotensin II Receptor Blockers Covered in This Study Table 5. Global Angiotensin II Receptor Blockers Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Angiotensin II Receptor Blockers Sales Share by Manufacturers (2016-2021) Table 7. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Angiotensin II Receptor Blockers Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Angiotensin II Receptor Blockers Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Angiotensin II Receptor Blockers Manufacturing Sites and Area Served Table 11. Manufacturers Angiotensin II Receptor Blockers Product Type Table 12. Global Angiotensin II Receptor Blockers Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Angiotensin II Receptor Blockers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin II Receptor Blockers as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Angiotensin II Receptor Blockers Sales by Region (2016-2021) & (K Units) Table 16. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021) Table 17. Global Angiotensin II Receptor Blockers Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units) Table 19. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021) Table 20. North America Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021) Table 22. Europe Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units) Table 23. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021) Table 24. Europe Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Angiotensin II Receptor Blockers Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Angiotensin II Receptor Blockers Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2021) Table 30. Latin America Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units) Table 31. Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021) Table 32. Latin America Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021) Table 38. Global Angiotensin II Receptor Blockers Sales (K Units) by Type (2016-2021) Table 39. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021) Table 40. Global Angiotensin II Receptor Blockers Revenue (Million US$) by Type (2016-2021) Table 41. Global Angiotensin II Receptor Blockers Revenue Share by Type (2016-2021) Table 42. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2016-2021) Table 43. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2016-2021) Table 44. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021) Table 45. Global Angiotensin II Receptor Blockers Revenue (Million US$) by Application (2016-2021) Table 46. Global Angiotensin II Receptor Blockers Revenue Share by Application (2016-2021) Table 47. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2016-2021) Table 48. Merck & Co. Corporation Information Table 49. Merck & Co. Description and Business Overview Table 50. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Merck & Co. Angiotensin II Receptor Blockers Product Table 52. Merck & Co. Recent Developments/Updates Table 53. AstraZeneca Corporation Information Table 54. AstraZeneca Description and Business Overview Table 55. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. AstraZeneca Angiotensin II Receptor Blockers Product Table 57. AstraZeneca Recent Developments/Updates Table 58. Novartis Corporation Information Table 59. Novartis Description and Business Overview Table 60. Novartis Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Novartis Angiotensin II Receptor Blockers Product Table 62. Novartis Recent Developments/Updates Table 63. Teva Corporation Information Table 64. Teva Description and Business Overview Table 65. Teva Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Teva Angiotensin II Receptor Blockers Product Table 67. Teva Recent Developments/Updates Table 68. Bayer Corporation Information Table 69. Bayer Description and Business Overview Table 70. Bayer Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Bayer Angiotensin II Receptor Blockers Product Table 72. Bayer Recent Developments/Updates Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Business Overview Table 75. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. GlaxoSmithKline Angiotensin II Receptor Blockers Product Table 77. GlaxoSmithKline Recent Developments/Updates Table 78. Sun Pharmaceutical Corporation Information Table 79. Sun Pharmaceutical Description and Business Overview Table 80. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sun Pharmaceutical Angiotensin II Receptor Blockers Product Table 82. Sun Pharmaceutical Recent Developments/Updates Table 83. Mylan Corporation Information Table 84. Mylan Description and Business Overview Table 85. Mylan Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Mylan Angiotensin II Receptor Blockers Product Table 87. Mylan Recent Developments/Updates Table 88. Production Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Angiotensin II Receptor Blockers Distributors List Table 91. Angiotensin II Receptor Blockers Customers List Table 92. Angiotensin II Receptor Blockers Market Trends Table 93. Angiotensin II Receptor Blockers Growth Drivers Table 94. Angiotensin II Receptor Blockers Market Restraints Table 95. Global Angiotensin II Receptor Blockers Sales Forecast by Type (2022-2027) & (K Units) Table 96. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Type (2022-2027) Table 97. Global Angiotensin II Receptor Blockers Revenue Forecast by Type (2022-2027) & (US$ Million) Table 98. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Type (2022-2027) Table 99. Global Angiotensin II Receptor Blockers Sales Forecast by Application (2022-2027) & (K Units) Table 100. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Application (2022-2027) Table 101. Global Angiotensin II Receptor Blockers Revenue Forecast by Application (2022-2027) & (US$ Million) Table 102. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Application (2022-2027) Table 103. Global Angiotensin II Receptor Blockers Sales Forecast by Region (2022-2027) & (K Units) Table 104. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Region (2022-2027) Table 105. Global Angiotensin II Receptor Blockers Revenue Forecast by Region (2022-2027) & (US$ Million) Table 106. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Region (2022-2027) Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Angiotensin II Receptor Blockers Figure 2. Global Angiotensin II Receptor Blockers Market Share by Type in 2020 & 2027 Figure 3. Azilsartan Product Picture Figure 4. Candesartan Product Picture Figure 5. Eprosartan Product Picture Figure 6. Irbesartan Product Picture Figure 7. Losartan Product Picture Figure 8. Olmesartan Product Picture Figure 9. Telmisartan Product Picture Figure 10. Valsartan Product Picture Figure 11. Global Angiotensin II Receptor Blockers Market Share by Application in 2020 & 2027 Figure 12. Chronic Kidney Diseases Figure 13. Heart Failure Figure 14. Kidney Failure in Diabetes Figure 15. Global Angiotensin II Receptor Blockers Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Angiotensin II Receptor Blockers Market Size 2016-2027 (US$ Million) Figure 17. Global Angiotensin II Receptor Blockers Sales 2016-2027 (K Units) Figure 18. Global Angiotensin II Receptor Blockers Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Angiotensin II Receptor Blockers Sales Share by Manufacturers in 2020 Figure 20. Global Angiotensin II Receptor Blockers Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Angiotensin II Receptor Blockers Players: Market Share by Revenue in 2020 Figure 22. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021) Figure 24. Global Angiotensin II Receptor Blockers Sales Market Share by Region in 2020 Figure 25. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2021) Figure 26. Global Angiotensin II Receptor Blockers Revenue Market Share by Region in 2020 Figure 27. U.S. Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. U.A.E Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Angiotensin II Receptor Blockers by Type (2016-2021) Figure 52. Sales Market Share of Angiotensin II Receptor Blockers by Application (2016-2021) Figure 53. Sales Market Share of Angiotensin II Receptor Blockers by Application in 2020 Figure 54. Revenue Share of Angiotensin II Receptor Blockers by Application (2016-2021) Figure 55. Revenue Share of Angiotensin II Receptor Blockers by Application in 2020 Figure 56. Manufacturing Cost Structure of Angiotensin II Receptor Blockers Figure 57. Manufacturing Process Analysis of Angiotensin II Receptor Blockers Figure 58. Angiotensin II Receptor Blockers Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Merck & Co. AstraZeneca Novartis Teva Bayer GlaxoSmithKline Sun Pharmaceutical Mylan